Bladder Cancer Clinical Trials in Guangzhou, Guangdong
12 recruitingGuangzhou, Guangdong, China
Showing 1–12 of 12 trials
Recruiting
Phase 3
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
Bladder Cancer
Merck Sharp & Dohme LLC590 enrolled21 locationsNCT07419295
Recruiting
Phase 1Phase 2
Clinical Trail of Neoadjuvant of Tislelizumab Combined With Palbociclib in Patients With Platinum-refractory Bladder Urothelial Carcinoma
Bladder Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University36 enrolled8 locationsNCT06364956
Recruiting
Bladder Cancer Staging and Prediction of New Adjuvant Chemotherapy Efficacy Based on Deep Learning and Transfer Learning in Ultrasound-Magnetic Resonance-Pathology Multimodal Multiscale
Bladder CancerNeoadjuvant ChemotherapyDeep Learning+2 more
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University480 enrolled1 locationNCT07051083
Recruiting
Ultrasound Contrast-Enhanced Accurate Diagnosis of Preoperative Staging of Bladder Cancer
Bladder CancerStagingContrast Enhanced Ultrasound
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University480 enrolled1 locationNCT06775977
Recruiting
Phase 1
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SIM0237 Alone or in Combination with BCG in NMIBC
Non-Muscle-Invasive Bladder Cancer (NMIBC)
Jiangsu Simcere Pharmaceutical Co., Ltd.152 enrolled14 locationsNCT06186414
Recruiting
Preoperative Detection of Muscle Invasion in Bladder Cancer with Contrast-enhanced Ultrasonography
Bladder Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University1,000 enrolled1 locationNCT05204108
Recruiting
Phase 1Phase 2
RC48 Combined with Toripalimab As Neoadjuvant Therapy for Cisplatin Ineligible MIBC Patients
Muscle-Invasive Bladder CarcinomaBladder Cancer
Zhujiang Hospital55 enrolled1 locationNCT06341400
Recruiting
Phase 2
Neoadjuvant Toripalimab in Combination with Gemcitabine and Cisplatin Therapy in Local Advanced Bladder Cancer Subjects
Urinary Bladder Cancer
Zhujiang Hospital41 enrolled1 locationNCT04861584
Recruiting
Not Applicable
Comparison of Safety and Efficacy of Detaenial Sigmoid Neobladder and Ileal Neobladder
Bladder CancerUrinary Diversion
Zhujiang Hospital96 enrolled1 locationNCT03108196
Recruiting
Not Applicable
Comparison Capsule Sparing Cystectomy and Radical Cystoprostatectomy in Men with Bladder Cancer
Bladder Cancer
Zhujiang Hospital126 enrolled1 locationNCT05067101
Recruiting
Phase 1Phase 2
To Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravesical Instiliations of Disitamab Vedotin in Patients With High-risk Non-muscular Invasive Bladder Cancer (NMIBC) That Express HER2
High-risk Non-muscle Invasive Bladder Cancer
RemeGen Co., Ltd.24 enrolled6 locationsNCT06378242
Recruiting
Phase 2
A Single-arm Phase II Clinical Study of the Efficacy and Safety of Camrelizumab Combined With GEMOX for Unresectable GBCs
Unresectable Gallbladder Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University37 enrolled1 locationNCT06423170